Back
Day Range
$139.00
$148.86
52-Week Range
$60.40
$212.75
Volume
1,913,017
50D / 200D Avg
$152.68
/
$147.77
Prev Close
$139.14
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -25.0 | 0.3 |
| P/B | 43.3 | 3.0 |
| ROE % | -249.3 | 3.7 |
| Net Margin % | -210.5 | 3.8 |
| Rev Growth 5Y % | 33.9 | 10.0 |
| D/E | 1.0 | 0.2 |
Analyst Price Target
Hold
$214.47
+44.6%
Low: $166.00
High: $269.00
Forward EPS
-$2.72
Est. Revenue
1.69B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.07
$8.40 – $14.24
|
6.51B | 6 |
| FY2029 |
$8.48
$6.44 – $10.91
|
5.21B | 10 |
| FY2028 |
$3.97
$0.90 – $7.23
|
3.87B | 15 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | -$1.07 | -$1.54 | -43.7% |
| 2025-10-30 | -$1.33 | -$1.75 | -31.6% |
| 2025-08-07 | -$1.30 | -$1.70 | -30.8% |
| 2025-05-08 | -$1.34 | -$1.42 | -6.0% |
| 2025-02-20 | -$1.17 | -$1.32 | -12.8% |
| 2024-10-31 | -$1.20 | -$1.27 | -5.8% |
| 2024-08-08 | -$1.24 | -$1.94 | -56.5% |
| 2024-05-09 | -$1.24 | -$1.06 | +14.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 33.93% annually over 5 years — strong growth
Negative free cash flow of -967.58M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 32.80%
Capital efficient — spends only 5.37% of revenue on capex
Growth
Revenue Growth (5Y)
33.93%
Revenue (1Y)66.73%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-249.28%
ROIC-58.56%
Net Margin-210.54%
Op. Margin-194.04%
Safety
Debt / Equity
1.04
Current Ratio3.83
Interest Coverage-14.04
Valuation
P/E Ratio
-25.04
Forward P/EN/A
P/B Ratio43.26
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 66.73% | Revenue Growth (3Y) | 40.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 606.42M | Net Income (TTM) | -1.28B |
| ROE | -249.28% | ROA | -56.38% |
| Gross Margin | 79.41% | Operating Margin | -194.04% |
| Net Margin | -210.54% | Free Cash Flow (TTM) | -967.58M |
| ROIC | -58.56% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.04 | Current Ratio | 3.83 |
| Interest Coverage | -14.04 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -25.04 | Forward P/E | N/A |
| P/B Ratio | 43.26 | P/S Ratio | 52.72 |
| PEG Ratio | -1.93 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 18.95 | Fwd Earnings Yield | N/A |
| FCF Yield | -3.03% | ||
| Market Cap | 31.97B | Enterprise Value | 32.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 606.42M | 363.71M | 305.21M | 245.36M | 188.46M |
| Net Income | -1.28B | -913.77M | -749.57M | -481.53M | -434.65M |
| EPS (Diluted) | -6.41 | -5.57 | -5.34 | -3.91 | -3.88 |
| Gross Profit | 481.55M | 277.97M | 239.64M | 190.23M | 144.31M |
| Operating Income | -1.18B | -878.25M | -709.63M | -457.32M | -375.09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.26B | 2.03B | 1.33B | 1.66B | 1.24B |
| Total Liabilities | 1.53B | 1.74B | 1.66B | 1.57B | 833.04M |
| Shareholders' Equity | 738.98M | 285.38M | -331.92M | 87.95M | 410.47M |
| Total Debt | 768.16M | 1.31B | 1.20B | 1.18B | 612.27M |
| Cash & Equivalents | 510.45M | 555.03M | 482.37M | 1.07B | 716.78M |
| Current Assets | 1.79B | 1.62B | 929.06M | 1.27B | 837.04M |
| Current Liabilities | 468.87M | 297.53M | 225.63M | 190.24M | 135.17M |